Your trusted source for investing success

Tag: investment advice

An Introduction to TSXV Life Science Stocks

An Introduction to TSXV Life Science Stocks

Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some medical device, genetics, pharmaceutical and biotech stocks currently trading on this exchange—as well as their area of focus.

Kootenay Silver Presentation at European Gold Forum 2017

Kootenay Silver Presentation at European Gold Forum 2017

James McDonald’s Presentation at the European Gold Forum 2017 is now on the Kootenay Silver Website. Please click the following link to view: http://www.europeangoldforum.org/egf17/company-webcast/KTN:CN/

For additional information, please contact:

James McDonald, CEO and President at 1.403.880.6016; or Investor Relations at 1.888.601.5650.

This message is not a solicitation of any order to buy or

Lexaria and NeutriSci Complete Cannabinoid Joint Venture

Lexaria and NeutriSci Complete Cannabinoid Joint Venture

Lexaria Bioscience (OTCQB:LXRP,CSE:LXX) and NeutriSci International Inc. have completed and signed the previously announced joint venture agreement to produce and commercialize a line of healthy, sugar-free, edible cannabinoid mouth-melt products which will utilize Lexaria’s patented technology and Neutrisci’s proprietary pterostilbene tablet form factor.

Lexaria Approaches Tipping Point with New Products & Financing

Lexaria Bioscience (OTCQB:LXRP,CSE:LXX) recently announced the launch of its TurboCBD™ brand of enhanced, high-absorption, full-spectrum hemp oil capsules. The capsules incorporate the company’s patented absorption technology — proven to increase CBD absorption by five to ten times compared to conventional preparations — along with the finest American Ginseng and Ginkgo

Gensource Potash on Track to Finish Vanguard FS in Q2

Gensource Potash on Track to Finish Vanguard FS in Q2

Gensource Potash (TSXV:GSP) is providing its shareholders an update on key corporate activities.

The ongoing Vanguard One Project Feasibility Study (“Study”) is over 75% complete and remains on track to be finished in Q2 2017. The Study is with respect to the Vanguard One Project, to be located on Gensource’s KL

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network